Predictors of response to exposure and response prevention-based cognitive behavioral therapy for obsessive-compulsive disorder.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
04 09 2020
Historique:
received: 29 03 2020
accepted: 27 08 2020
entrez: 5 9 2020
pubmed: 6 9 2020
medline: 30 12 2020
Statut: epublish

Résumé

Cognitive behavioral therapy (CBT), which includes exposure and response prevention (ERP), is effective in improving symptoms of obsessive-compulsive disorder (OCD). However, whether poor cognitive functions and autism spectrum disorder (ASD) traits affect the therapeutic response of patients with OCD to ERP-based CBT remains unclear. This study aimed to identify factors predictive of the therapeutic response of Japanese patients with OCD to ERP-based CBT. Forty-two Japanese outpatients with OCD were assessed using the Wechsler Adult Intelligence Scale-III (WAIS-III), Yale-Brown Obsessive-Compulsive Scale, Patient Health Questionnaire 9-item scale, and Autism Spectrum Quotient (AQ) at pre- and post-treatment. We used multiple regression analyses to estimate the effect on therapeutic response change. The treatment response change was set as a dependent variable in multiple regression analyses. Multiple regression analyses showed that among independent variables, communication as an AQ sub-scale and Letter Number Sequencing as a WAIS-III sub-test predict the therapeutic response to ERP-based CBT . Our results suggest that diminished working memory (Letter Number Sequencing), poor communication skill (AQ sub-scale) may undermine responsiveness to ERP-based CBT among patients with OCD. UMIN, UMIN00024087 . Registered 20 September 2016 - Retrospectively registered (including retrospective data).

Sections du résumé

BACKGROUND
Cognitive behavioral therapy (CBT), which includes exposure and response prevention (ERP), is effective in improving symptoms of obsessive-compulsive disorder (OCD). However, whether poor cognitive functions and autism spectrum disorder (ASD) traits affect the therapeutic response of patients with OCD to ERP-based CBT remains unclear. This study aimed to identify factors predictive of the therapeutic response of Japanese patients with OCD to ERP-based CBT.
METHODS
Forty-two Japanese outpatients with OCD were assessed using the Wechsler Adult Intelligence Scale-III (WAIS-III), Yale-Brown Obsessive-Compulsive Scale, Patient Health Questionnaire 9-item scale, and Autism Spectrum Quotient (AQ) at pre- and post-treatment. We used multiple regression analyses to estimate the effect on therapeutic response change. The treatment response change was set as a dependent variable in multiple regression analyses.
RESULTS
Multiple regression analyses showed that among independent variables, communication as an AQ sub-scale and Letter Number Sequencing as a WAIS-III sub-test predict the therapeutic response to ERP-based CBT .
CONCLUSIONS
Our results suggest that diminished working memory (Letter Number Sequencing), poor communication skill (AQ sub-scale) may undermine responsiveness to ERP-based CBT among patients with OCD.
TRIAL REGISTRATION
UMIN, UMIN00024087 . Registered 20 September 2016 - Retrospectively registered (including retrospective data).

Identifiants

pubmed: 32887553
doi: 10.1186/s12888-020-02841-4
pii: 10.1186/s12888-020-02841-4
pmc: PMC7473813
doi:

Banques de données

UMIN-CTR
['UMIN000024087']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

433

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : JP20dm0307002
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 16K04344
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 16K04342
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 19K03309
Pays : International
Organisme : Japan Society for the Promotion of Science
ID : 19J00227
Pays : International

Références

Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Depress Anxiety. 2016 Sep;33(9):848-61
pubmed: 27100799
Seishin Shinkeigaku Zasshi. 1999;101(2):152-68
pubmed: 10375975
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Psychiatry Res. 2015 Jul 30;228(1):8-13
pubmed: 25935374
J Anxiety Disord. 2008 May;22(4):734-49
pubmed: 17913454
Front Psychiatry. 2017 Aug 15;8:143
pubmed: 28861007
J Dev Phys Disabil. 2018 Feb;30(1):69-87
pubmed: 29568212
Clin Psychol Rev. 2008 Jan;28(1):118-130
pubmed: 17531365
J Psychiatr Res. 2013 Jan;47(1):33-41
pubmed: 22999486
BMC Res Notes. 2014 May 20;7:306
pubmed: 24884936
Cortex. 2013 May;49(5):1195-205
pubmed: 22789779
Int J Clin Health Psychol. 2015 Sep-Dec;15(3):181-190
pubmed: 30487835
Can J Psychiatry. 2006 Jun;51(7):407-16
pubmed: 16838822
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):310-7
pubmed: 22789662
Neuropsychologia. 2002;40(2):205-11
pubmed: 11640942
J Neuropsychiatry Clin Neurosci. 2001 Fall;13(4):508-10
pubmed: 11748320
BMC Psychiatry. 2016 Jul 07;16:220
pubmed: 27388205
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
JMIR Ment Health. 2019 Nov 15;6(11):e15747
pubmed: 31730037
J Anxiety Disord. 2002;16(2):207-19
pubmed: 12194545
Clin Child Fam Psychol Rev. 2011 Sep;14(3):302-17
pubmed: 21735077
Psychother Psychosom. 2005;74(5):269-76
pubmed: 16088264
Psychol Med. 2010 Dec;40(12):2013-23
pubmed: 20416137
Am J Psychiatry. 2005 Jan;162(1):151-61
pubmed: 15625214
J Clin Psychiatry. 2008 Apr;69(4):621-32
pubmed: 18363421
Behav Res Ther. 2002 May;40(5):529-39
pubmed: 12038645
J Med Internet Res. 2018 Dec 17;20(12):e12091
pubmed: 30559094
Clin Psychol Rev. 2013 Dec;33(8):1067-81
pubmed: 24077387
Behav Res Ther. 2005 Jun;43(6):811-9
pubmed: 15959930
J Am Acad Child Adolesc Psychiatry. 1999 Mar;38(3):322-8
pubmed: 10087694
Psychol Rep. 2007 Dec;101(3 Pt 1):952-60
pubmed: 18232454
Nord J Psychiatry. 2016;70(3):183-9
pubmed: 26329120
J Consult Clin Psychol. 1983 Apr;51(2):287-97
pubmed: 6841773
Psychother Psychosom. 2012;81(2):124-6
pubmed: 22301680
Shinrigaku Kenkyu. 2004 Apr;75(1):78-84
pubmed: 15724518
Behav Res Ther. 2004 Feb;42(2):217-27
pubmed: 14975782
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754

Auteurs

Sayo Hamatani (S)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Japan Society for the Promotion of Science, Tokyo, Japan.

Aki Tsuchiyagaito (A)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Laureate Institute for Brain Research, Tulsa, OK, USA.

Masato Nihei (M)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.

Yuta Hayashi (Y)

Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Graduate School of Medicine and Veterinary Medicine, University of Miyazaki, Miyazaki, Japan.

Tokiko Yoshida (T)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.

Jumpei Takahashi (J)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.

Sho Okawa (S)

Graduate School of Medicine and Veterinary Medicine, University of Miyazaki, Miyazaki, Japan.
United Graduate School of Child Development, Osaka University Research Center of Child Mental Development, Chiba University, Chiba, Japan.

Honami Arai (H)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.

Maki Nagaoka (M)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.

Kazuki Matsumoto (K)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.

Eiji Shimizu (E)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Cognitive Behavioral Therapy Center, Chiba University Hospital, Chiba, Japan.

Yoshiyuki Hirano (Y)

Research Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan. hirano@chiba-u.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH